Akari Therapeutics (AKTX) Enterprise Value Growth (5y) (2016 - 2025)
Akari Therapeutics (AKTX) Enterprise Value Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 57.92% |
| Jun 30, 2025 | 26.30% |
| Mar 31, 2025 | 19.51% |
| Dec 31, 2024 | 14.24% |
| Sep 30, 2024 | 18.56% |
| Jun 30, 2024 | -8.82% |
| Mar 31, 2024 | 26.59% |
| Dec 31, 2023 | -49.10% |
| Dec 31, 2022 | -147.65% |
| Sep 30, 2020 | 31.00% |
| Jun 30, 2020 | -36.22% |
| Mar 31, 2020 | -42.56% |
| Dec 31, 2019 | -11.49% |
| Sep 30, 2019 | -160.14% |
| Jun 30, 2019 | 24.77% |
| Mar 31, 2019 | 14.97% |
| Dec 31, 2018 | 1.18% |
| Dec 31, 2017 | 33.62% |
| Dec 31, 2016 | -493.33% |